TR60
Tirzepatide 60mg (Research Chemical)
Dual GLP-1 & GIP Receptor Agonist for Advanced Metabolic Research
Tirzepatide is a next-generation research peptide designed for scientific exploration of metabolic regulation, weight management, and glucose homeostasis. This dual agonist targets both the GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors, offering a powerful tool for studying hormonal pathways involved in appetite control, insulin sensitivity, and energy balance.
Key Highlights
Potency: Dual GLP-1/GIP receptor agonist
Quantity: 60mg lyophilized peptide (1 vial)
Purity: >99% (HPLC-verified)
Form: Lyophilized powder for reconstitution
Research Focus: Obesity, diabetes, insulin sensitivity, metabolic syndrome
Included in Kit
1 x Tirzepatide 60mg vial
1 x 3ml bacteriostatic water (for reconstitution)
1 x 3ml mixing syringe
2 x alcohol wipes
General reconstitution guideline (for laboratory use only)
Intended Use & Safety
For Research Use Only:
Not for human or veterinary use. Not intended for diagnostic, therapeutic, or medical treatment purposes.Handling:
Use in a controlled laboratory setting by qualified professionals. Follow appropriate safety protocols.Storage:
Store lyophilized peptide at –20°C to –80°C. Protect from light and moisture. Reconstituted solution should be refrigerated and used within research parameters.
Why Tirzepatide 60mg?
With its dual-receptor activity, Tirzepatide represents a breakthrough in the exploration of metabolic modulation. Researchers investigating obesity, type 2 diabetes, and hormone signaling can leverage this high-purity peptide to gain deeper insights into the synergistic effects of GLP-1 and GIP receptor agonism.
Disclaimer: This compound is sold strictly for laboratory research. By purchasing, you agree to use it in accordance with all local laws and research regulations.
Tirzepatide 60mg (Research Chemical)
Dual GLP-1 & GIP Receptor Agonist for Advanced Metabolic Research
Tirzepatide is a next-generation research peptide designed for scientific exploration of metabolic regulation, weight management, and glucose homeostasis. This dual agonist targets both the GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors, offering a powerful tool for studying hormonal pathways involved in appetite control, insulin sensitivity, and energy balance.
Key Highlights
Potency: Dual GLP-1/GIP receptor agonist
Quantity: 60mg lyophilized peptide (1 vial)
Purity: >99% (HPLC-verified)
Form: Lyophilized powder for reconstitution
Research Focus: Obesity, diabetes, insulin sensitivity, metabolic syndrome
Included in Kit
1 x Tirzepatide 60mg vial
1 x 3ml bacteriostatic water (for reconstitution)
1 x 3ml mixing syringe
2 x alcohol wipes
General reconstitution guideline (for laboratory use only)
Intended Use & Safety
For Research Use Only:
Not for human or veterinary use. Not intended for diagnostic, therapeutic, or medical treatment purposes.Handling:
Use in a controlled laboratory setting by qualified professionals. Follow appropriate safety protocols.Storage:
Store lyophilized peptide at –20°C to –80°C. Protect from light and moisture. Reconstituted solution should be refrigerated and used within research parameters.
Why Tirzepatide 60mg?
With its dual-receptor activity, Tirzepatide represents a breakthrough in the exploration of metabolic modulation. Researchers investigating obesity, type 2 diabetes, and hormone signaling can leverage this high-purity peptide to gain deeper insights into the synergistic effects of GLP-1 and GIP receptor agonism.
Disclaimer: This compound is sold strictly for laboratory research. By purchasing, you agree to use it in accordance with all local laws and research regulations.